logo
PGF Capital Berhad (KLSE:PGF) Is Experiencing Growth In Returns On Capital

PGF Capital Berhad (KLSE:PGF) Is Experiencing Growth In Returns On Capital

Yahoo23-02-2025
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. So when we looked at PGF Capital Berhad (KLSE:PGF) and its trend of ROCE, we really liked what we saw.
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for PGF Capital Berhad, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.091 = RM29m ÷ (RM351m - RM37m) (Based on the trailing twelve months to November 2024).
Therefore, PGF Capital Berhad has an ROCE of 9.1%. In absolute terms, that's a low return, but it's much better than the Building industry average of 7.0%.
View our latest analysis for PGF Capital Berhad
In the above chart we have measured PGF Capital Berhad's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering PGF Capital Berhad for free.
While in absolute terms it isn't a high ROCE, it's promising to see that it has been moving in the right direction. Over the last five years, returns on capital employed have risen substantially to 9.1%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 47%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.
All in all, it's terrific to see that PGF Capital Berhad is reaping the rewards from prior investments and is growing its capital base. And with the stock having performed exceptionally well over the last five years, these patterns are being accounted for by investors. Therefore, we think it would be worth your time to check if these trends are going to continue.
One more thing to note, we've identified 2 warning signs with PGF Capital Berhad and understanding these should be part of your investment process.
While PGF Capital Berhad isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MOGU Full Year 2025 Earnings: CN¥7.14 loss per share (vs CN¥6.85 loss in FY 2024)
MOGU Full Year 2025 Earnings: CN¥7.14 loss per share (vs CN¥6.85 loss in FY 2024)

Yahoo

time6 hours ago

  • Yahoo

MOGU Full Year 2025 Earnings: CN¥7.14 loss per share (vs CN¥6.85 loss in FY 2024)

Explore MOGU's Fair Values from the Community and select yours MOGU (NYSE:MOGU) Full Year 2025 Results Key Financial Results Revenue: CN¥141.2m (down 12% from FY 2024). Net loss: CN¥62.6m (loss widened by 5.5% from FY 2024). CN¥7.14 loss per share (further deteriorated from CN¥6.85 loss in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period MOGU shares are down 2.9% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 1 warning sign for MOGU you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Krystal Biotech Second Quarter 2025 Earnings: Beats Expectations
Krystal Biotech Second Quarter 2025 Earnings: Beats Expectations

Yahoo

time6 hours ago

  • Yahoo

Krystal Biotech Second Quarter 2025 Earnings: Beats Expectations

Explore Krystal Biotech's Fair Values from the Community and select yours Krystal Biotech (NASDAQ:KRYS) Second Quarter 2025 Results Key Financial Results Revenue: US$96.0m (up 37% from 2Q 2024). Net income: US$38.3m (up 146% from 2Q 2024). Profit margin: 40% (up from 22% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$1.33 (up from US$0.54 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Krystal Biotech Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 14%. Looking ahead, revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 12% from a week ago. Risk Analysis It is worth noting though that we have found 1 warning sign for Krystal Biotech that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sohu.com Second Quarter 2025 Earnings: US$0.69 loss per share (vs US$1.16 loss in 2Q 2024)
Sohu.com Second Quarter 2025 Earnings: US$0.69 loss per share (vs US$1.16 loss in 2Q 2024)

Yahoo

time6 hours ago

  • Yahoo

Sohu.com Second Quarter 2025 Earnings: US$0.69 loss per share (vs US$1.16 loss in 2Q 2024)

Explore Fair Values from the Community and select yours (NASDAQ:SOHU) Second Quarter 2025 Results Key Financial Results Revenue: US$126.3m (down 27% from 2Q 2024). Net loss: US$20.0m (loss narrowed by 47% from 2Q 2024). US$0.69 loss per share (improved from US$1.16 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Earnings Insights Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 10% growth forecast for the Entertainment industry in the US. Performance of the American Entertainment industry. The company's shares are down 3.4% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 1 warning sign for you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store